Acetamide, 2-methoxy-N-[2-(phenylmethyl)phenyl]-

Acetamide, 2-methoxy-N-[2-(phenylmethyl)phenyl]- Suppliers list
Company Name: China National Standard Pharmaceutical Corporation Limited
Tel: +8615391658522
Email: overseasales@yongstandards.com
Products Intro: Product Name:Epinastine Impurity 25
CAS:1110929-19-5
Purity:0.95 Package:Vials
Company Name: Hubei Yangxin Medical Technology Co., Ltd.  
Tel: 15374522761
Email: 3003392093@qq.com
Products Intro: Product Name:Epinastine Impurity 25
CAS:1110929-19-5
Purity:95% HPLC Package:10mg;25mg;50mg;100mg
Company Name: Shenzhen Botel Biotechnology Co. Ltd.  
Tel: 0755-22202135 13316968096
Email: 1979313431@qq.com
Products Intro: Product Name:Epinastine Impurity 8
CAS:1110929-19-5
Purity:98% HPLC Package:10mg;25mg;50mg
Company Name: TOSUN PHARM  
Tel: 020-61855200 13326451905
Email: 260366801@qq.com
Products Intro: Product Name:Epinastine Impurity 32
CAS:1110929-19-5
Purity:97.76% Package:5mg;10mg;50mg Remarks:REF-E04037
Company Name: Nanjing wangzhixing Pharmaceutical Technology Co., Ltd  
Tel: 15850510341
Email: shiqingran@wzxchem.com
Products Intro: Product Name:Epinastine Impurity 13
CAS:1110929-19-5
Purity:98% HPLC Package:mg;g
Acetamide, 2-methoxy-N-[2-(phenylmethyl)phenyl]- Basic information
Product Name:Acetamide, 2-methoxy-N-[2-(phenylmethyl)phenyl]-
Synonyms:Acetamide, 2-methoxy-N-[2-(phenylmethyl)phenyl]-;Epinastine Impurity 25;Chloropyramine Impurity 1
CAS:1110929-19-5
MF:C16H17NO2
MW:255.31
EINECS:
Product Categories:
Mol File:1110929-19-5.mol
Acetamide, 2-methoxy-N-[2-(phenylmethyl)phenyl]- Structure
Acetamide, 2-methoxy-N-[2-(phenylmethyl)phenyl]- Chemical Properties
Boiling point 434.5±38.0 °C(Predicted)
density 1.135±0.06 g/cm3(Predicted)
pka13.63±0.70(Predicted)
Safety Information
MSDS Information
Acetamide, 2-methoxy-N-[2-(phenylmethyl)phenyl]- Usage And Synthesis
Acetamide, 2-methoxy-N-[2-(phenylmethyl)phenyl]- Preparation Products And Raw materials
Tag:Acetamide, 2-methoxy-N-[2-(phenylmethyl)phenyl]-(1110929-19-5) Related Product Information
L-Aspartic acid, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-, (1→3')-disulfide with L-tryptophyl-L-prolyl-L-cysteinamide (9CI) Eptifibatide impurity 3/Deamidated Eptifibatide Impurity/(3R,11S,17S,20S,25aS)-20-((1H-indol-3-yl)Methyl)-17-(carboxymethyl)-11-(4-guanidinobutyl)-1,9,12,15,18,21-hexaoxodocosahydro-1H-pyrrolo[2,1-g][1,2,5,8,11,14,17,20]dithiahexaazacyclotricosine-3-carbo Cyclo(L-Pro-L-Trp-) L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, bimol. cyclic (1→1'),(6→6')-bis(disulfide) N-[2-(Phenylmethyl)phenyl]-2-chloroacetamide Methanone, (2-aminophenyl)phenyl-, hydrazone, (Z)- L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, cyclic (1→7)-disulfide (9CI) Benzamide, N-[(6,11-dihydro-5H-dibenz[b,e]azepin-6-yl)methyl]-2-(hydroxymethyl)- 7-Bromo Epinastine Eptifibatide non cyclic impurity 3'-Hydroxyacetophenone 6-Chloromethylmorphanthridine Acetamide, 2-(1-methylethoxy)-N-[2-(phenylmethyl)phenyl]-